Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

treatment And NotPierre Pollak

List of bibliographic references

Number of relevant bibliographic references: 26.
Ident.Authors (with country if any)Title
000127 Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study
000155 Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni]Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?
000245 Rodger Elble [États-Unis, Allemagne] ; Günther Deuschl [Allemagne]Milestones in tremor research
000254 Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche]Milestones in Parkinson's disease therapeutics
000342 Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis]Determination of minimal clinically important change in early and advanced Parkinson's disease
000524 David J. Burn [Royaume-Uni]The Treatment of Cognitive Impairment Associated with Parkinson's Disease
000532 Claire L. Tomlinson [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Richard Gray [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni]Systematic review of levodopa dose equivalency reporting in Parkinson's disease
000569 Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000826 Manon Bouchard [Canada] ; Sylvain Chouinard [Canada] ; And Oksana Suchowersky [Canada]Adult cases of congenital muscular torticollis successfully treated with botulinum toxin
000A43 Robert A. Hauser [États-Unis] ; Mark F. Lew [États-Unis] ; Howard I. Hurtig [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Cheryl J. Fitzer-Attas [Israël]Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
000A47 Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis] ; David Oakes [États-Unis]Levodopa response in early Parkinson's disease
000B07 Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
000B80 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
000C63 Robert A. Hauser [États-Unis] ; Lisa M. Shulman [États-Unis] ; Joel M. Trugman [États-Unis] ; John W. Roberts [États-Unis] ; Akihisa Mori [Japon] ; Rocco Ballerini [États-Unis] ; Neil M. Sussman [États-Unis]Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
000D54 Nir Giladi [Israël]Medical treatment of freezing of gait
000F43 Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
000F68 G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède]Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
001101 Paul T. Francis [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni]Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
001222 Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon]Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations
001399 Hasmet A. Hanagasi ; Murat Emre [Turquie]Treatment of behavioural symptoms and dementia in Parkinson's disease
001534 Daniel Weintraub [États-Unis] ; Knashawn H. Morales [États-Unis] ; Paul J. Moberg [États-Unis] ; Warren B. Bilker [États-Unis] ; Catherine Balderston [États-Unis] ; John E. Duda [États-Unis] ; Ira R. Katz [États-Unis] ; Matthew B. Stern [États-Unis]Antidepressant studies in Parkinson's disease: A review and meta‐analysis
001634 Bastiaan R. Bloem [Pays-Bas] ; Jeffrey M. Hausdorff [Israël, États-Unis] ; Jasper E. Visser [Pays-Bas] ; Nir Giladi [Israël]Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
001793 David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni]Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease
001811 Shingo Okabe [Japon] ; Yoshikazu Ugawa [Japon] ; Ichiro Kanazawa [Japon]0.2‐Hz repetitive transcranial magnetic stimulation has no add‐on effects as compared to a realistic sham stimulation in Parkinson's disease
001911 D. J. Burn [Royaume-Uni]Depression in Parkinson's disease
001933 David J. Burn [Royaume-Uni]Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024